Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report

• Autori principali: Baldwin Kaitlyn PharmD (Autore), Wanson Annabelle MD, FRCPC (Autore), Gilecki Lee-Anne MD, FRCPC (Autore), Dalton Courtney BSP (Autore), Peters Evyn MD, FRCPC (Autore), Halpape Katelyn BSP, ACPR, PharmD, BCPP (Autore)
• Natura: Libro
• Pubblicazione: American Association of Psychiatric Pharmacists, 2023-10-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limited efficacy in the presence of inflammation. Although ketamine has shown promis...